This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignees: Icahn School of Medicine at Mount Sinai, The United States Government as Represented by the Department of Veterans Affairs, University of Kansas. Active years: 2020-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 2020-2026
Title: Kyung Lee: Innovator in Kidney Fibrosis Treatment
Introduction
Kyung Lee is a notable inventor based in New York, NY (US). He has made significant contributions to the field of medical research, particularly in the treatment of kidney fibrosis. His innovative work has led to the development of a patent that addresses critical health issues.
Latest Patents
Kyung Lee holds a patent for "Oxadiazole inhibitors of HIPK2 for treating kidney fibrosis." This patent discloses compounds that are selective inhibitors of Smad3 activation. The compounds have a specific structure where Z is an oxadiazole. These compounds are particularly useful in treating fibrotic diseases, especially renal fibrosis, and similar conditions associated with the dysregulation of the HIPK2/Smad3 signaling pathway. He has 1 patent to his name.
Career Highlights
Throughout his career, Kyung Lee has worked with prestigious institutions such as the Icahn School of Medicine at Mount Sinai and the University of Kansas. His research has focused on developing innovative solutions to complex medical problems.
Collaborations
Kyung Lee has collaborated with talented individuals in his field, including Ruijie Liu and Wenzhen Xiao. Their combined expertise has contributed to advancing research in kidney fibrosis and related areas.
Conclusion
Kyung Lee's contributions to the field of kidney fibrosis treatment through his innovative patent demonstrate his commitment to improving health outcomes. His work continues to inspire future research and development in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile